Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors

Sep 30, 2026 · Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 30, 2026

Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

(601607)"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Isavuconazonium Sulfate for InjectionSep 29
(601607)"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Esomeprazole Magnesium Enteric-coated CapsulesSep 29
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Approval for Production of Paclitaxel InjectionSep 29
"Shanghai Pharmaceuticals Holding Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 11

All Shanghai Pharmaceuticals Holding Co. Ltd. Class A news releases